Reply To: Ocrelizumab – a breakthrough?

Today, Jan 07, 2022 I mentioned to my Neurologist, a member of this group’s Medical Advisory Board, that the subject of Ocrelizumab for my treatment of IVIG/MMN was mentioned.  Here is his reply, “I do not recommend Ocrelizumab. It would be more appropriate to stay the course with IVIG and see where things are at in a few months. Depending on that response it is not unreasonable to consider other medications, but not ocrelizumab. Rituximab (a very similar medication) would be a more reasonable medication – but again, that would really be down the road depending on how IVIG played out.”